Riskpilot← Back to searchSign inGet full accessBIOMATICS TECHNOLOGY ApS
APSActiveCVR 36451491Strandpromenaden 39Manufacture of optical instruments, magnetic and optical media and photographic equipment · NACE 2670Est. 20141 employeesBiomaticstechnology.com
Revenue 2024
DKK 3K
-99% vs 2023
EBITDA margin
-17935.9%
-196% vs 2023
Equity ratio
92.0%
Financial strength
Net profit 2024
DKK -314K
-3530% vs 2023
| Revenue | DKK 3K | -99% |
| EBITDA | DKK -590K | -196% |
| Net profit | DKK -314K | -3530% |
| Total assets | DKK 1,4M | -44% |
| Equity | DKK 1,3M | -46% |
| Employees | 1 | — |
Legal name
BIOMATICS TECHNOLOGY ApS
CVR number
36451491
Legal form
Anpartsselskab
NACE code
2670 · Manufacture of optical instruments, magnetic and optical media and photographic equipment
Founded
1. december 2014
Share capital
DKK 710.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren alene
Company purpose
Selskabets formål er at drive virksomhed indenfor udvikling og salg af instrumenter samt anden beslægtet virksomhed
Address
Strandpromenaden 39
Phone
+4521355342
Email
christian.lysholm@biomaticstech.com
Website
Biomaticstechnology.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -79 | -527 | 1.720 | 360 | 342 | 445 | 2.338 | 628 | 465 | 3 |
| Staff expenses | -329 | -969 | -515 | -27 | -332 | -251 | -596 | -563 | -665 | -594 |
| EBITDA | -408 | -1.496 | 1.206 | 334 | 10 | 194 | 1.742 | 65 | -200 | -590 |
| Depreciation & amort. | -0 | -40 | -6.552 | -419 | -100 | -100 | -100 | -100 | -0 | -0 |
| EBIT | -408 | -1.536 | -5.346 | -85 | -90 | 94 | 1.642 | -35 | -200 | -590 |
| Net financials | -130 | -415 | 7.173 | -0 | 0 | -0 | 59 | -314 | 214 | 191 |
| Profit before tax | -537 | -1.950 | 1.826 | -85 | -90 | 94 | 1.701 | -349 | 14 | -399 |
| Tax | -134 | -476 | -583 | -19 | -18 | 22 | 376 | -72 | 5 | -85 |
| Net profit | -403 | -1.474 | 2.409 | -67 | -72 | 72 | 1.325 | -277 | 9 | -314 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.030 | 5.372 | 1.899 | 1.334 | 1.327 | 1.602 | 3.458 | 2.433 | 2.468 | 1.395 |
| Equity | 297 | -1.177 | 1.232 | 1.165 | 1.093 | 1.315 | 2.641 | 2.364 | 2.373 | 1.283 |
| Long-term debt | 3.371 | 6.024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 220 | 384 | 557 | 81 | 168 | 242 | 795 | 69 | 95 | 111 |
| Total debt | 3.591 | 6.408 | 557 | 81 | 168 | 242 | 795 | 69 | 95 | 111 |
EBITDA margin
-17935.9%
This company
15.8%
Market median
-113618% vs market
20152024
Equity ratio
92.0%
This company
38.2%
Market median
+141% vs market
20152024
Return on equity
-24.4%
This company
18.4%
Market median
-233% vs market
20152024
Net profit margin
-9526.3%
This company
8.1%
Market median
-117709% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2014-12-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CE Management | Management | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CWL GROUP ApS | Company | 100.0% | 100.0% | 2017 |
Styrelsen for Forskning og Uddannelse | Company | 20.0% | 20.0% | 2016 |
Uddannelses- og Forskningsstyrelsen | Company | 33.3% | 33.3% | 2014 |
FONDEN SPRING NORDIC | Company | 25.0% | 25.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CWL GROUP ApS
BIOMATICS TECHNOLOGY ApS Board members of BIOMATICS TECHNOLOGY ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Erik Wittenborg Lysholm | Management | 0 companies |
| Anders Holme Jensen | Chairman | 0 companies |
| Jesper Bryde-Jacobsen | Board of Directors | 0 companies |
| Knud Odgaard Pedersen | Board of Directors | 0 companies |